{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:18:26Z","timestamp":1794057506769,"version":"4.8.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470834"],"award-info":[{"award-number":["81470834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860109"],"award-info":[{"award-number":["81860109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.aohep.2023.101121","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T13:46:27Z","timestamp":1686404787000},"page":"101121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms"],"prefix":"10.1016","volume":"28","author":[{"given":"Xiaoyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4727-9307","authenticated-orcid":false,"given":"Long","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangmao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2023.101121_bib0001","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aohep.2023.101121_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/hep.30145","article-title":"Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases","volume":"69","author":"Lindor","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0003","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s12016-010-8234-y","article-title":"Overcoming a \u201cprobable\u201d diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature","volume":"42","author":"Bizzaro","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.aohep.2023.101121_bib0004","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/liv.14688","article-title":"Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis","volume":"41","author":"Haldar","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101121_bib0005","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jhep.2004.11.016","article-title":"Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis","volume":"42","author":"Nakamura","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101121_bib0006","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaut.2005.10.007","article-title":"Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis","volume":"26","author":"Nakamura","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2023.101121_bib0007","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/apt.13927","article-title":"The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210","volume":"45","author":"Yang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2023.101121_bib0008","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/hepr.12423","article-title":"Autoantibody status and histological variables influence biochemical response to treatment and long-term outcomes in Japanese patients with primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/j.aohep.2023.101121_bib0009","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0168-8278(98)80233-X","article-title":"The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis","volume":"28","author":"Luettig","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2023.101121_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1006\/jaut.1997.0156","article-title":"Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis","volume":"10","author":"Mattalia","year":"1997","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2023.101121_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1746.1998.01553.x","article-title":"Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis","volume":"13","author":"Itoh","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2023.101121_bib0012","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1572-0241.2003.07257.x","article-title":"Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis","volume":"98","author":"Muratori","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101121_bib0013","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","article-title":"Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis","volume":"45","author":"Nakamura","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0014","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/hep.30604","article-title":"Genome-wide Association Studies of Specific Antinuclear Autoantibody Subphenotypes in Primary Biliary Cholangitis","volume":"70","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0896-8411(03)00033-7","article-title":"Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study","volume":"20","author":"Miyachi","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2023.101121_bib0016","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.510230512","article-title":"Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis","volume":"23","author":"Bandin","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0017","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/hep.21678","article-title":"Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis","volume":"45","author":"Bogdanos","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0018","first-page":"1024","article-title":"Chinese Medical Association","volume":"60","year":"2021","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.aohep.2023.101121_bib0019","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.clinre.2020.03.026","article-title":"Treatment of primary biliary cholangitis with ursodeoxycholic acid, prednisolone and immunosuppressants in patients not responding to ursodeoxycholic acid alone and the prognostic indicators","volume":"44","author":"Qian","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101121_bib0020","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF00918255","article-title":"Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis","volume":"5","author":"Ruffatti","year":"1985","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aohep.2023.101121_bib0021","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1084\/jem.178.6.2237","article-title":"Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210","volume":"178","author":"Nickowitz","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.aohep.2023.101121_bib0022","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1084\/jem.182.4.1159","article-title":"Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210","volume":"182","author":"Wesierska-Gadek","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.aohep.2023.101121_bib0023","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.dld.2021.10.011","article-title":"The prognostic value of antibodies to gp210 among patients with primary biliary cholangitis in Northeast China","volume":"54","author":"Chen","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.aohep.2023.101121_bib0024","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/liv.12560","article-title":"Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis","volume":"35","author":"Quarneti","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2023.101121_bib0025","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0034-1383732","article-title":"Clinical significance of autoantibodies in primary biliary cirrhosis","volume":"34","author":"Nakamura","year":"2014","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.aohep.2023.101121_bib0026","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1365-2036.2006.03172.x","article-title":"Antinuclear antibodies giving the 'multiple nuclear dots' or the 'rim-like\/membranous' patterns: diagnostic accuracy for primary biliary cirrhosis","volume":"24","author":"Granito","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.aohep.2023.101121_bib0027","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/hep.1840080438","article-title":"Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis","volume":"8","author":"Lozano","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2023.101121_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1172\/JCI114696","article-title":"The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore","volume":"86","author":"Courvalin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2023.101121_bib0029","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1080\/08916930802709133","article-title":"Multiple nuclear dots and rim-like\/membranous IgG isotypes in primary biliary cirrhosis","volume":"42","author":"Muratori","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.aohep.2023.101121_bib0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1586\/erm.11.82","article-title":"Antinuclear antibodies as ancillary markers in primary biliary cirrhosis","volume":"12","author":"Granito","year":"2012","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.aohep.2023.101121_bib0031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14309\/ajg.0000000000000928","article-title":"Surrogate Markers for Antimitochondrial Antibody-Negative Primary Biliary Cholangitis","volume":"116","author":"Granito","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.aohep.2023.101121_bib0032","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.molcel.2004.12.010","article-title":"The integral membrane nucleoporin pom121 functionally links nuclear pore complex assembly and nuclear envelope formation","volume":"17","author":"Antonin","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.aohep.2023.101121_bib0033","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1083\/jcb.108.6.2083","article-title":"Primary structure analysis of an integral membrane glycoprotein of the nuclear pore","volume":"108","author":"Wozniak","year":"1989","journal-title":"J Cell Biol"},{"key":"10.1016\/j.aohep.2023.101121_bib0034","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/j.1460-2075.1990.tb08267.x","article-title":"A major glycoprotein of the nuclear pore complex is a membrane-spanning polypeptide with a large lumenal domain and a small cytoplasmic tail","volume":"9","author":"Greber","year":"1990","journal-title":"EMBO J"},{"key":"10.1016\/j.aohep.2023.101121_bib0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","article-title":"Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy","volume":"67","author":"Tang","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2023.101121_bib0036","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.aohep.2023.101121_bib0037","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1073\/pnas.77.7.3884","article-title":"Vesicular stomatitis virus glycoprotein is anchored in the viral membrane by a hydrophobic domain near the COOH terminus","volume":"77","author":"Rose","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.aohep.2023.101121_bib0038","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1073\/pnas.71.10.3988","article-title":"Location of the spike glycoproteins in the Semliki Forest virus membrane","volume":"71","author":"Garoff","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.aohep.2023.101121_bib0039","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.mi.43.100189.002341","article-title":"Structural domains and organizational conformation involved in the sorting and transport of influenza virus transmembrane proteins","volume":"43","author":"Nayak","year":"1989","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.aohep.2023.101121_bib0040","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/labinvest.2010.40","article-title":"Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation","volume":"90","author":"Haruta","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/j.aohep.2023.101121_bib0041","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0016-5085(03)00387-1","article-title":"Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis","volume":"124","author":"Shimoda","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2023.101121_bib0042","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2249.2012.04577.x","article-title":"Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent","volume":"168","author":"Yang","year":"2012","journal-title":"Clin Exp Immunol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268123002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:45:16Z","timestamp":1761648316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268123002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1665268123002259"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101121","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2023.101121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101121"}}